`
`TRADEMARK
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDINGA PATENT OR
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`filed in the U.S. District Court
`for the District of Delaware
`on the following
`
`(] Trademarks or
`
`(Patents.
`
`( (1 thepatent action involves 35 U.S.C. § 292.):
`
`HORIZON MEDICINES LLC and NUVO
`PHARMACEUTICALS(IRELAND) DESIGNATED
`ACTIVITY COMPANY
`
`DEFENDANT
`
`AJANTA PHARMALTD. and AJANTA PHARMA USA,
`
`INC.,
`HOLDER OF PATENT OR TRADEMARK
`DECISION/JUDGEMENT CLERK
`
`DATE INCLUDED
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`PATENT OR
`TRADEMARK NO.
`
`C1 Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`C1 Answer
`
`C1 CrossBill
`
`C1] Other Pleading
`
`In the above—entitled case, the following decision has been rendered or judgementissued:
`
`(BY) DEPUTY CLERK
`
`DATE
`
`Copy 1—Uponinitiation of action, mail this copy to Director Copy 3—Upontermination of action, mail this copy to Director
`Copy 2—Uponfiling document adding patent(s), mail this copy to Director Copy 4—Casefile copy
`
`
`
`Case 1:19-cv-01814-RGA Document4 Filed 09/27/19 Page 2 of 2 PagelD #: 176
`
`HOLDER OF PATENT OR TRADEMARK
`
`Designated
`
`Designated
`
`Designated
`
`Designated
`
`Designated
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`9,345,695
`
`8,852,636
`
`8,858,996
`
`9,161,920
`
`9,198,888
`
`9,707,181
`
`5/24/2016
`
`10/7/2014
`
`10/14/2014
`
`10/20/2015
`
`12/1/2015
`
`7/18/2017
`
`(Ireland)
`
`(Ireland)
`
`(Ireland)
`
`(Ireland)
`
`(Ireland)
`
`Nuvo Pharmaceuticals (Ireland) Designated Activity
`Company
`Nuvo Pharmaceuticals
`Activity Compan
`Nuvo Pharmaceuticals
`Activity Compan
`Nuvo Pharmaceuticals
`Activity Compan
`Nuvo Pharmaceuticals
`Activity Company
`Nuvo Pharmaceuticals
`Activity Company
`
`